ChemLifeIntel
Access

Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe

TRACKED

CASHSN
THERAPEUTIC AREAS
MOLECULE INTELLIGENCE SNAPSHOTlive
14
Manufacturers monitored
38
Intelligence briefs
3
Active regulatory actions
₹2,800 Cr
Est. India export value

INTELLIGENCE

Showing 1 of 1 briefs for Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe
REGULATORY INTELLIGENCE·Recall

Redline Pharmacy Solutions Recalls Intrathecal Morphine Sulfate Due to Critical Processing Control Lapses

Redline Pharmacy Solutions initiated a Class II recall of intrathecal Morphine Sulfate due to a critical 'Lack of Processing Controls'. This event, impacting patients in Nebraska, underscores the imperative for robust quality management in compounding pharmacies. Procurement and regulatory teams must scrutinize supplier quality systems for high-risk medications, even from regional distributors, to mitigate patient safety and supply chain risks.

90-Day Activity
RMRohan Mehta· Senior Supply Chain Intelligence Analyst
2020-03-18